Patents by Inventor Sabine Karine Katrien INGHELBRECHT

Sabine Karine Katrien INGHELBRECHT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Freeze dried drug nanosuspensions
    Patent number: 11819502
    Abstract: The present invention relates to a freeze-dried (also called lyophilized) drug nanosuspension. The present freeze-dried drug nanosuspension composition has an acceptable stability of the particle size distribution during storage, including long term storage.
    Type: Grant
    Filed: June 6, 2022
    Date of Patent: November 21, 2023
    Assignee: Janssen Pharmaceutica NV
    Inventors: Sabine Karine Katrien Inghelbrecht, Jakob Andreas Beirowski, Henning Gieseler
  • Aqueous pharmaceutical formulation of tapentadol for oral administration
    Patent number: 11547678
    Abstract: An aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof and being adapted for oral administration. The composition has excellent storage stability without relying on the presence of high amounts of preservatives.
    Type: Grant
    Filed: October 24, 2019
    Date of Patent: January 10, 2023
    Assignee: Gruenenthal GmbH
    Inventors: Ulrich Reinhold, Marc Schiller, Eva Wulsten, Sabine Karine Katrien Inghelbrecht, Roger Carolus Augusta Embrechts, Ulrich Feil
  • FREEZE DRIED DRUG NANOSUSPENSIONS
    Publication number: 20220409616
    Abstract: The present invention relates to a freeze-dried (also called lyophilized) drug nanosuspension. The present freeze-dried drug nanosuspension composition has an acceptable stability of the particle size distribution during storage, including long term storage.
    Type: Application
    Filed: June 6, 2022
    Publication date: December 29, 2022
    Inventors: Sabine Karine Katrien Inghelbrecht, Jakob Andreas Beirowski, Henning Gieseler
  • Freeze dried drug nanosuspensions
    Patent number: 11389448
    Abstract: The present invention relates to a freeze-dried (also called lyophilized) drug nanosuspension. The present freeze-dried drug nanosuspension composition has an acceptable stability of the particle size distribution during storage, including long term storage.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: July 19, 2022
    Assignee: Janssen Pharmaceutica NV
    Inventors: Sabine Karine Katrien Inghelbrecht, Jakob Andreas Beirowski, Henning Gieseler
  • PARENTERAL ADMINISTRATION OF TAPENTADOL
    Publication number: 20200215003
    Abstract: An aqueous pharmaceutical composition adapted for parenteral administration of tapentadol or a physiologically acceptable salt thereof having a pH value of at least 5.4.
    Type: Application
    Filed: March 13, 2020
    Publication date: July 9, 2020
    Applicant: GRÜNENTHAL GMBH
    Inventors: Thomas CHRISTOPH, Sabine Karine Katrien INGHELBRECHT, Roger Carolus Augusta EMBRECHTS, Ulrich REINHOLD, Marc SCHILLER, Eva WULSTEN, Petra BLOMS-FUNKE, Klaus SCHIENE, Ulrich FEIL
  • AQUEOUS PHARMACEUTICAL FORMULATION OF TAPENTADOL FOR ORAL ADMINISTRATION
    Publication number: 20200054584
    Abstract: An aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof and being adapted for oral administration. The composition has excellent storage stability without relying on the presence of high amounts of preservatives.
    Type: Application
    Filed: October 24, 2019
    Publication date: February 20, 2020
    Applicant: GRÜNENTHAN GMBH
    Inventors: Ulrich REINHOLD, Marc SCHILLER, Eva WULSTEN, Sabine Karine Katrien INGHELBRECHT, Roger Carolus Augusta EMBRECHTS, Ulrich FEIL
  • FREEZE DRIED DRUG NANOSUSPENSIONS
    Publication number: 20190076428
    Abstract: The present invention relates to a freeze-dried (also called lyophilized) drug nanosuspension. The present freeze-dried drug nanosuspension composition has an acceptable stability of the particle size distribution during storage, including long term storage.
    Type: Application
    Filed: November 8, 2018
    Publication date: March 14, 2019
    Inventors: Sabine Karine Katrien Inghelbrecht, Jakob Andreas Beirowski, Henning Gieseler
  • Freeze dried drug nanosuspensions
    Patent number: 10166231
    Abstract: The present invention relates to a freeze-dried (also called lyophilized) drug nanosuspension. The present freeze-dried drug nanosuspension composition has an acceptable stability of the particle size distribution during storage, including long term storage.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: January 1, 2019
    Assignee: Janssen Pharmaceutica NV
    Inventors: Sabine Karine Katrien Inghelbrecht, Jakob Andreas Beirowski, Henning Gieseler
  • Semisolid Aqueous Pharmaceutical Composition Containing Tapentadol
    Publication number: 20180133174
    Abstract: A semisolid aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof.
    Type: Application
    Filed: January 10, 2018
    Publication date: May 17, 2018
    Inventors: Ulrich REINHOLD, Marc SCHILLER, Eva WULSTEN, Sabine Karine Katrien INGHELBRECHT, Roger Carolus Augusta EMBRECHTS, Ulrich FEIL
  • Semisolid Aqueous Pharmaceutical Composition Containing Tapentadol
    Publication number: 20160346229
    Abstract: A semisolid aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof.
    Type: Application
    Filed: August 10, 2016
    Publication date: December 1, 2016
    Inventors: Ulrich REINHOLD, Marc SCHILLER, Eva WULSTEN, Sabine Karine Katrien INGHELBRECHT, Roger Carolus Augusta EMBRECHTS, Ulrich FEIL
  • FREEZE DRIED DRUG NANOSUSPENSIONS
    Publication number: 20160317534
    Abstract: The present invention relates to a freeze-dried (also called lyophilized) drug nanosuspension. The present freeze-dried drug nanosuspension composition has an acceptable stability of the particle size distribution during storage, including long term storage.
    Type: Application
    Filed: July 7, 2016
    Publication date: November 3, 2016
    Inventors: Sabine Karine Katrien Inghelbrecht, Jakob Andreas Beirowski, Henning Gieseler
  • Semisolid aqueous pharmaceutical composition containing tapentadol
    Patent number: 9446008
    Abstract: A semisolid aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: September 20, 2016
    Assignee: Gruenenthal GmbH
    Inventors: Ulrich Reinhold, Marc Schiller, Eva Wulsten, Sabine Karine Katrien Inghelbrecht, Roger Carolus Augusta Embrechts, Ulrich Feil
  • Aqueous Pharmaceutical Formulation of Tapentadol for Oral Administration
    Publication number: 20160220516
    Abstract: An aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof and being adapted for oral administration. The composition has excellent storage stability without relying on the presence of high amounts of preservatives.
    Type: Application
    Filed: April 7, 2016
    Publication date: August 4, 2016
    Inventors: Ulrich REINHOLD, Marc SCHILLER, Eva WULSTEN, Sabine Karine Katrien INGHELBRECHT, Roger Carolus Augusta EMBRECHTS, Ulrich FEIL
  • Parenteral Administration of Tapentadol
    Publication number: 20160106688
    Abstract: An aqueous pharmaceutical composition adapted for parenteral administration of tapentadol or a physiologically acceptable salt thereof having a pH value of at least 5.4.
    Type: Application
    Filed: December 28, 2015
    Publication date: April 21, 2016
    Inventors: Thomas CHRISTOPH, Sabine Karine Katrien INGHELBRECHT, Roger Carolus Augusta EMBRECHTS, Ulrich REINHOLD, Marc SCHILLER, Eva WULSTEN, Petra BLOMS-FUNKE, Klaus SCHIENE, Ulrich FEIL
  • Freeze Dried Drug Nanosuspensions
    Publication number: 20140038996
    Abstract: The present invention relates to a freeze-dried (also called lyophilized) drug nanosuspension. The present freeze-dried drug nanosuspension composition has an acceptable stability of the particle size distribution during storage, including long term storage.
    Type: Application
    Filed: April 13, 2012
    Publication date: February 6, 2014
    Applicant: Janssen Pharmaceutica NV
    Inventors: Sabine Karine Katrien Inghelbrecht, Jakob Andreas Beirowski, Henning Gieseler
  • Aqueous Pharmaceutical Formulation of Tapentadol for Oral Administration
    Publication number: 20130022670
    Abstract: An aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof and being adapted for oral administration. The composition has excellent storage stability without relying on the presence of high amounts of preservatives.
    Type: Application
    Filed: March 2, 2012
    Publication date: January 24, 2013
    Applicant: Gruenenthal GmbH
    Inventors: Ulrich REINHOLD, Marc Schiller, Eva Wulsten, Sabine Karine Katrien Inghelbrecht, Roger Carolus Augusta Embrechts
  • Parenteral Administration of Tapentadol
    Publication number: 20120225951
    Abstract: An aqueous pharmaceutical composition adapted for parenteral administration of tapentadol or a physiologically acceptable salt thereof having a pH value of at least 5.4.
    Type: Application
    Filed: March 2, 2012
    Publication date: September 6, 2012
    Applicant: Gruenenthal GmbH
    Inventors: Thomas CHRISTOPH, Sabine Karine Katrien Inghelbrecht, Roger Carolus Augusta Embrechts
  • Semisolid Aqueous Pharmaceutical Composition Containing Tapentadol
    Publication number: 20120225950
    Abstract: A semisolid aqueous pharmaceutical composition containing tapentadol or a physiologically acceptable salt thereof.
    Type: Application
    Filed: March 2, 2012
    Publication date: September 6, 2012
    Applicant: Gruenenthal GmbH
    Inventors: Ulrich REINHOLD, Marc SCHILLER, Eva WULSTEN, Sabine Karine Katrien INGHELBRECHT, Roger Carolus Augusta EMBRECHTS